JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for EVIDENCE-BASED-HEALTH Archives


EVIDENCE-BASED-HEALTH Archives

EVIDENCE-BASED-HEALTH Archives


March 2020


View:

Show Author | Hide Author

LISTSERV Archives

LISTSERV Archives

EVIDENCE-BASED-HEALTH Home

EVIDENCE-BASED-HEALTH Home

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject

From

Date Sorted by Date, Most Recent First

Size

Re: Oxford CEBM paper on mortality CoVID-19

Rod Jackson

Tue, 31 Mar 2020 22:10:45 +0000

1131 lines

Re: Ioannidis paper on CoVID-19

David Richard Leslie Cawthorpe

Tue, 31 Mar 2020 21:53:36 +0000

898 lines

Re: Oxford CEBM paper on mortality CoVID-19

Rod Jackson

Tue, 31 Mar 2020 21:50:25 +0000

988 lines

Re: Ioannidis paper on CoVID-19

Anoop B

Tue, 31 Mar 2020 17:45:45 -0400

1231 lines

Re: Ioannidis paper on CoVID-19

Barry Diner

Tue, 31 Mar 2020 16:07:15 -0500

1196 lines

Re: Oxford CEBM paper on mortality CoVID-19

Kelleher, Kevin

Tue, 31 Mar 2020 20:56:15 +0000

1009 lines

Re: Ioannidis paper on CoVID-19

Gerd Antes

Tue, 31 Mar 2020 22:53:51 +0200

358 lines

Re: Oxford CEBM paper on mortality CoVID-19

Kelleher, Kevin

Tue, 31 Mar 2020 20:49:54 +0000

936 lines

Re: Oxford CEBM paper on mortality CoVID-19

Carlos A.

Tue, 31 Mar 2020 17:49:03 -0300

1312 lines

Re: Oxford CEBM paper on mortality CoVID-19

Rod Jackson

Tue, 31 Mar 2020 20:40:36 +0000

939 lines

Re: Ioannidis paper on CoVID-19

Bill Cayley, Jr

Tue, 31 Mar 2020 18:56:15 +0000

1041 lines

Re: Oxford CEBM paper on mortalaity CoVID-19

Myles, Nickolas [PH]

Tue, 31 Mar 2020 18:54:59 +0000

879 lines

Re: [nmamembers2012] STUFF on CoVID-19

Moacyr Roberto Cuce Nobre

Tue, 31 Mar 2020 12:57:50 -0300

911 lines

Re: Ioannidis paper on CoVID-19

Benjamin Djulbegovic MD

Tue, 31 Mar 2020 15:36:32 +0000

662 lines

Re: [nmamembers2012] STUFF on CoVID-19

Chuck A. Simpson

Tue, 31 Mar 2020 14:23:48 +0000

1179 lines

Re: [nmamembers2012] STUFF on CoVID-19

joseph ana

Tue, 31 Mar 2020 12:47:31 +0000

863 lines

Virtual academic, not live, conference - Business & Economics

Helen Kantarelis

Tue, 31 Mar 2020 08:33:01 -0400

77 lines

Re: Ioannidis paper on CoVID-19

David Richard Leslie Cawthorpe

Tue, 31 Mar 2020 12:27:11 +0000

511 lines

Re: Ioannidis paper on CoVID-19

Carl Heneghan

Tue, 31 Mar 2020 13:14:52 +0100

545 lines

Re: Ioannidis paper on CoVID-19

Oleg Borisenko

Tue, 31 Mar 2020 11:45:39 +0200

532 lines

Re: Ioannidis paper on CoVID-19

joseph ana

Tue, 31 Mar 2020 09:39:48 +0000

527 lines

Re: Ioannidis paper on CoVID-19

Dr Amy Price

Tue, 31 Mar 2020 00:06:04 -0400

354 lines

Re: Ioannidis paper on CoVID-19

Anoop B

Mon, 30 Mar 2020 23:24:39 -0400

206 lines

keeping perspective

Bewley, Susan

Tue, 31 Mar 2020 02:55:36 +0000

403 lines

Re: Ioannidis paper on CoVID-19

Ogston, Jena

Mon, 30 Mar 2020 19:24:10 -0500

173 lines

CoVID-19 tracking graphic with multiple countries at a glance...

David Richard Leslie Cawthorpe

Mon, 30 Mar 2020 23:30:54 +0000

51 lines

Re: Ioannidis paper on CoVID-19

Anoop B

Mon, 30 Mar 2020 18:32:43 -0400

113 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Huw Llewelyn [hul2]

Mon, 30 Mar 2020 22:26:32 +0000

351 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Rod Jackson

Mon, 30 Mar 2020 21:50:05 +0000

219 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

McCormack, James

Mon, 30 Mar 2020 21:44:03 +0000

193 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Benjamin Djulbegovic MD

Mon, 30 Mar 2020 21:36:14 +0000

327 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Rod Jackson

Mon, 30 Mar 2020 21:28:14 +0000

314 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Dr Amy Price

Mon, 30 Mar 2020 17:22:18 -0400

366 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Bill Cayley, Jr

Mon, 30 Mar 2020 21:18:19 +0000

275 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Jon Brassey

Mon, 30 Mar 2020 22:18:06 +0100

238 lines

Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)

Rod Jackson

Mon, 30 Mar 2020 21:13:43 +0000

151 lines

Re: Masks on or off?

Benjamin Djulbegovic MD

Mon, 30 Mar 2020 18:43:46 +0000

260 lines

Masks on or off?

Tom Jefferson

Mon, 30 Mar 2020 19:00:10 +0200

98 lines

COVID-19 Rapid Review - hydroxychloroquine

McCormack, James

Mon, 30 Mar 2020 16:44:45 +0000

90 lines

33 online research methods / data analytics courses

Geoffrey Hubona

Sun, 29 Mar 2020 16:09:13 -0700

25 lines

Ioannidis paper on CoVID-19

David Richard Leslie Cawthorpe

Sun, 29 Mar 2020 14:50:57 +0000

65 lines

Re: Communicating negative results for COVID-19?

Kelleher, Kevin

Sun, 29 Mar 2020 10:31:35 +0000

564 lines

Re: Communicating negative results for COVID-19?

Donald E. Stanley

Sun, 29 Mar 2020 10:02:47 +0000

120 lines

Re: Communicating negative results for COVID-19?

Huw Llewelyn [hul2]

Sun, 29 Mar 2020 09:15:18 +0000

177 lines

Re: Communicating negative results for COVID-19?

David Richard Leslie Cawthorpe

Sat, 28 Mar 2020 20:56:58 +0000

124 lines

Communicating negative results for COVID-19?

Shaughnessy, Allen

Sat, 28 Mar 2020 16:02:17 -0400

106 lines

Re: mGAP WHO Covid-19 mental health resources

Craig Lockwood

Sat, 28 Mar 2020 03:04:19 +0000

217 lines

mGAP WHO Covid-19 mental health resources

David Richard Leslie Cawthorpe

Sat, 28 Mar 2020 02:37:37 +0000

128 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Benjamin Djulbegovic MD

Fri, 27 Mar 2020 22:39:17 +0000

607 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

McCormack, James

Fri, 27 Mar 2020 22:14:45 +0000

288 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Su May

Sat, 28 Mar 2020 05:54:49 +0800

328 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Bill Cayley, Jr

Fri, 27 Mar 2020 21:52:31 +0000

175 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Huw Llewelyn [hul2]

Fri, 27 Mar 2020 21:47:58 +0000

50 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Huw Llewelyn [hul2]

Fri, 27 Mar 2020 21:44:18 +0000

328 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Shaughnessy, Allen

Fri, 27 Mar 2020 17:25:05 -0400

332 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Huw Llewelyn [hul2]

Fri, 27 Mar 2020 21:22:10 +0000

193 lines

Estimating affected population by COVID19

beatrice muraguri

Fri, 27 Mar 2020 16:11:59 +0000

89 lines

COVD-19: Can population exposure be estimated from the death rate?

David Richard Leslie Cawthorpe

Fri, 27 Mar 2020 14:05:45 +0000

55 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Baijayanta Mukhopadhyay

Fri, 27 Mar 2020 09:50:53 -0400

67 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Anoop B

Thu, 26 Mar 2020 23:16:41 -0400

605 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Benjamin Djulbegovic MD

Fri, 27 Mar 2020 01:01:30 +0000

441 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Huw Llewelyn [hul2]

Thu, 26 Mar 2020 23:56:59 +0000

308 lines

Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Benjamin Djulbegovic MD

Thu, 26 Mar 2020 22:58:31 +0000

114 lines

Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms

Huw Llewelyn [hul2]

Thu, 26 Mar 2020 18:34:21 +0000

50 lines

Webinars on COVID-19 and doing fieldwork

Silvana di Gregorio

Thu, 26 Mar 2020 14:19:22 +0000

69 lines

CoVID-19 spread model out of Oxford

David Richard Leslie Cawthorpe

Thu, 26 Mar 2020 12:47:17 +0000

61 lines

Re: Country wise Age Distribution Covid Deaths-Data?

Michael Power

Wed, 25 Mar 2020 16:06:25 +0000

225 lines

Country wise Age Distribution Covid Deaths-Data?

Dr Danish Ahmad

Thu, 26 Mar 2020 01:55:07 +1100

358 lines

Need to conference call globally about the COVID-19 pandemic?

David Richard Leslie Cawthorpe

Wed, 25 Mar 2020 05:57:13 +0000

59 lines

Interactive interface representing COVID-19 Global cases

David Richard Leslie Cawthorpe

Wed, 25 Mar 2020 05:48:44 +0000

49 lines

Re: COVID-19 and high quality evidence

Manitoba Hunter

Tue, 24 Mar 2020 20:51:00 +0000

414 lines

Re: COVID-19 and high quality evidence

Orkan Okan

Tue, 24 Mar 2020 21:25:03 +0100

218 lines

Re: COVID-19 and high quality evidence

Jon Brassey

Tue, 24 Mar 2020 20:14:35 +0000

179 lines

Re: COVID-19 and high quality evidence

Craig Lockwood

Tue, 24 Mar 2020 20:11:34 +0000

162 lines

Re: German pulmonologist's important commentary on coronavirus-19

Dr Amy Price

Tue, 24 Mar 2020 15:56:46 -0400

112 lines

COVID-19 and high quality evidence

Jon Brassey

Tue, 24 Mar 2020 18:23:12 +0000

60 lines

Re: German pulmonologist's important commentary on coronavirus-19

Dr Amy Price

Tue, 24 Mar 2020 14:00:23 -0400

138 lines

Covid-19 Tracking and informational model to consider

David Richard Leslie Cawthorpe

Tue, 24 Mar 2020 13:20:06 +0000

67 lines

Re: German pulmonologist's important commentary on coronavirus-19

Myles, Nickolas [PH]

Mon, 23 Mar 2020 20:15:19 +0000

293 lines

Re: German pulmonologist's important commentary on coronavirus-19

Benjamin Djulbegovic MD

Mon, 23 Mar 2020 19:59:07 +0000

226 lines

Re: German pulmonologist's important commentary on coronavirus-19

Myles, Nickolas [PH]

Mon, 23 Mar 2020 19:45:09 +0000

83 lines

Re: COVID19 individual patient database ...

Benjamin Djulbegovic MD

Mon, 23 Mar 2020 18:09:37 +0000

310 lines

Re: COVID19 individual patient database ...

Vivek Podder

Mon, 23 Mar 2020 23:41:11 +0600

212 lines

COVID-19 - "the day after" China suspended the isolation measures

Lelia Carvalho

Mon, 23 Mar 2020 13:59:45 -0300

58 lines

Re: COVID19 individual patient database ...

Rakesh Biswas

Mon, 23 Mar 2020 21:49:23 +0530

143 lines

COVID19 individual patient database ...

Benjamin Djulbegovic MD

Mon, 23 Mar 2020 14:21:14 +0000

49 lines

Re: Advice for taking an evidence-based approach to COVID-19 research

Neal Maskrey

Mon, 23 Mar 2020 07:29:33 +0000

568 lines

Re: Advice for taking an evidence-based approach to COVID-19 research

Mohammed T. Ansari

Sun, 22 Mar 2020 22:03:53 -0400

349 lines

Re: Investigating Overdiagnosis and Overtreatment

Carlos A.

Sun, 22 Mar 2020 20:00:27 -0300

446 lines

Re: Advice for taking an evidence-based approach to COVID-19 research

Shadia Constantine

Mon, 23 Mar 2020 07:53:03 +0900

292 lines

Re: Advice for taking an evidence-based approach to COVID-19 research

Benjamin Djulbegovic MD

Sun, 22 Mar 2020 21:42:38 +0000

427 lines

Re: German pulmonologist's important commentary on coronavirus-19

Dr Amy Price

Sun, 22 Mar 2020 14:49:54 -0400

78 lines

Re: German pulmonologist's important commentary on coronavirus-19

Barry Diner

Sun, 22 Mar 2020 12:09:02 -0500

320 lines

Paper Invitation for Special Issue "Applied Medical Statistics: Theory, Computation, Applicability"

Polychronis Kostoulas

Sun, 22 Mar 2020 16:41:39 +0000

226 lines

Advice for taking an evidence-based approach to COVID-19 research

Shaughnessy, Allen

Sun, 22 Mar 2020 12:11:38 -0400

242 lines

Re: German pulmonologist's important commentary on coronavirus-19

David Richard Leslie Cawthorpe

Sun, 22 Mar 2020 15:16:16 +0000

195 lines

Re: German pulmonologist's important commentary on coronavirus-19

Mohammed T. Ansari

Sun, 22 Mar 2020 11:09:33 -0400

181 lines

Re: German pulmonologist's important commentary on coronavirus-19

Jeremy Howick

Sun, 22 Mar 2020 14:46:56 +0000

164 lines

Re: German pulmonologist's important commentary on coronavirus-19

Anoop B

Sun, 22 Mar 2020 10:25:53 -0400

148 lines

Re: German pulmonologist's important commentary on coronavirus-19

Benjamin Djulbegovic MD

Sun, 22 Mar 2020 13:51:43 +0000

55 lines

Re: German pulmonologist's important commentary on coronavirus-19

Michael Power

Sun, 22 Mar 2020 08:43:32 +0000

433 lines

Re: German pulmonologist's important commentary on coronavirus-19

David Richard Leslie Cawthorpe

Sat, 21 Mar 2020 22:08:52 +0000

161 lines

Re: German pulmonologist's important commentary on coronavirus-19

Michael Power

Sat, 21 Mar 2020 19:21:36 +0000

156 lines

German pulmonologist's important commentary on coronavirus-19

David Richard Leslie Cawthorpe

Sat, 21 Mar 2020 17:16:19 +0000

62 lines

Re: Investigating Overdiagnosis and Overtreatment

Benjamin Djulbegovic MD

Sat, 21 Mar 2020 15:15:26 +0000

256 lines

Investigating Overdiagnosis and Overtreatment

Vivek Podder

Sat, 21 Mar 2020 18:56:36 +0600

84 lines

Re: RE best evidence for primary care doctors and GPs especially in LMIC

Jon Brassey

Fri, 20 Mar 2020 06:05:26 +0000

187 lines

Re: RE best evidence for primary care doctors and GPs especially in LMIC

Su May

Fri, 20 Mar 2020 08:08:49 +0800

166 lines

RE best evidence for primary care doctors and GPs especially in LMIC

Kumara Mendis

Fri, 20 Mar 2020 05:32:50 +0530

131 lines

Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online

Benjamin Djulbegovic MD

Thu, 19 Mar 2020 14:37:11 +0000

376 lines

Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online

Homa Keshavarz

Thu, 19 Mar 2020 10:35:11 -0400

461 lines

Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online

Benjamin Djulbegovic MD

Thu, 19 Mar 2020 14:20:13 +0000

270 lines

Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online

usman khan

Thu, 19 Mar 2020 12:02:15 +0000

258 lines

OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online

Caroline DeBrun

Thu, 19 Mar 2020 10:27:38 +0000

228 lines

COVID 19→Bibliometric Dashboard with Altmetric Data (New Version)

Ernesto Barrera

Thu, 19 Mar 2020 08:01:55 +0100

108 lines

Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology

Tom Jefferson

Wed, 18 Mar 2020 08:53:08 +0100

152 lines

Re: Evidence & COVID 19

David Nunan

Thu, 12 Mar 2020 09:55:14 +0000

320 lines

Re: Tom Jefferson: Covid 19—we live in surreal times

Wouter Havinga

Wed, 11 Mar 2020 22:36:42 +0000

19 lines

Re: Tom Jefferson: Covid 19—we live in surreal times

Wouter Havinga

Wed, 11 Mar 2020 22:29:32 +0000

66 lines

Re: Evidence & COVID 19

Ernesto Barrera

Wed, 11 Mar 2020 12:35:27 +0100

204 lines

Re: Evidence & COVID 19

Tom Jefferson

Wed, 11 Mar 2020 12:00:17 +0100

67 lines

Re: Evidence & COVID 19

David Nunan

Wed, 11 Mar 2020 09:40:30 +0000

245 lines

Applications open for the only MRes OR Prof Doc in Occupational Health, Psychology and Management

Raluca Matei

Sat, 7 Mar 2020 20:03:21 +0000

501 lines

Re: Evidence & COVID 19

Tom Jefferson

Fri, 6 Mar 2020 22:37:00 +0100

217 lines

Evidence & COVID 19

David Nunan

Fri, 6 Mar 2020 19:15:12 +0000

146 lines

Scoping Reviews

Craig Lockwood

Thu, 5 Mar 2020 21:33:00 +0000

177 lines

Tom Jefferson: Covid 19—we live in surreal times

Tom Jefferson

Thu, 5 Mar 2020 17:03:08 +0100

52 lines

Re: Is this a trial?

Anoop B

Tue, 3 Mar 2020 18:14:09 -0500

1440 lines

Key paper on validity of new MCAT

David Richard Leslie Cawthorpe

Mon, 2 Mar 2020 17:39:08 +0000

69 lines

Covid 19—many questions, no clear answers

Tom Jefferson

Mon, 2 Mar 2020 18:37:41 +0100

63 lines

Applications open for the only MRes OR Prof Doc in Occupational Health, Psychology and Management

Raluca Matei

Sun, 1 Mar 2020 21:50:18 +0000

375 lines

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager